3 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
| Phase 2 | 2 | Unknown 2 |
Follow Sunitinib: new trials by email Literature Review of Sunitinib trials Research Report on Sunitinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC) Sunitinib Malate, TAS 102 - Colorectal Cancer, Metastasis | Phase 2 / Phase 3 | Unknown | Amsterdam UMC, location VUmc | 60 | 2019-10-01 | 2020-11-13 |
| A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme Sunitinib, Lomustine - Glioblastoma Multiforme, Glioblastoma, Adult | Phase 2 / Phase 3 | Unknown | Amsterdam UMC, location VUmc | 100 | 2018-08-31 | 2021-04-19 |
| Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting Trimebutine Maleate (NEWBUTIN SR 300 mg Tab), Metoclopramide hydrochloride monohydrate - Nausea, Vomiting | Phase 3 | Unknown | CM Chungmu Hospital | 45 | 2013-10-01 | 2013-11-15 |
Brain Neoplasms (1) · Colorectal Neoplasms (1) · Glioblastoma (1) · Nausea (1) · Neoplasm Metastasis (1) · Vomiting (1)
Amsterdam UMC, location VUmc (2) · CM Chungmu Hospital (1)
Netherlands (2) · South Korea (1)
Henk Verheul, Prof. M.D. (1) · Myra E Van Linde, MD (1) · Paolo Alan B Tabar, MD (1)